LaMattina: Drugmakers don't shirk social responsibilities

12/6/2013 | Forbes

Comments by Bayer CEO Marijn Dekkers that drug innovation is focused on serving markets willing and able to bear the cost of development are true, but that doesn't mean pharmaceutical companies are ignoring their responsibility to focus on neglected diseases as well, John LaMattina writes. Drugmakers support initiatives to help patients afford medicines as well as research into cures for non-Western diseases, he writes.

View Full Article in: